Parallel Advisors, LLC Beam Therapeutics Inc. Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 87 shares of BEAM stock, worth $2,092. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87
Previous 86 1.16%
Holding current value
$2,092
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$22.57 - $33.14 $22 - $33
1 Added 1.16%
87 $2,000
Q4 2023

Feb 09, 2024
SELL
$17.69 - $30.76 $4,015 - $6,982
-227 Reduced 72.52%
86 $2,000
Q3 2023

May 20, 2024
BUY
$23.01 - $32.46 $6,903 - $9,738
300 Added 2307.69%
313 $7,000
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $6,903 - $9,738
300 Added 2307.69%
313 $7,000
Q2 2023

May 20, 2024
SELL
$29.32 - $35.99 $1,290 - $1,583
-44 Reduced 77.19%
13 $0
Q2 2023

Aug 04, 2023
SELL
$29.32 - $35.99 $1,290 - $1,583
-44 Reduced 77.19%
13 $0
Q1 2023

May 20, 2024
SELL
$30.15 - $48.79 $874 - $1,414
-29 Reduced 33.72%
57 $1,000
Q1 2023

Apr 25, 2023
SELL
$30.15 - $48.79 $11,336 - $18,345
-376 Reduced 86.84%
57 $1,000
Q4 2022

Feb 03, 2023
BUY
$36.73 - $51.6 $14,508 - $20,382
395 Added 1039.47%
433 $16,000
Q3 2022

Nov 10, 2022
BUY
$39.79 - $70.31 $557 - $984
14 Added 58.33%
38 $2,000
Q2 2022

Aug 01, 2022
SELL
$29.86 - $62.36 $627 - $1,309
-21 Reduced 46.67%
24 $1,000
Q1 2022

Apr 28, 2022
SELL
$53.73 - $82.16 $3,331 - $5,093
-62 Reduced 57.94%
45 $3,000
Q4 2021

Jan 20, 2022
BUY
$68.02 - $99.06 $5,985 - $8,717
88 Added 463.16%
107 $9,000
Q3 2021

Nov 02, 2021
BUY
$84.37 - $133.6 $759 - $1,202
9 Added 90.0%
19 $2,000
Q4 2020

Feb 02, 2021
BUY
$22.24 - $95.63 $222 - $956
10 New
10 $1,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.69B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email